个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共9条记录   The ISoP Bengt-Erik Wiholm Memorial Lecture [作者：Edwards, IR,期刊：Drug safety, 页码：181-185 , 文章类型： Editorial Material，,卷期：2009年32-3] Pharmacogenetics and Pharmacovigilance [作者：Howland, RH,期刊：Drug safety, 页码：265-270 , 文章类型： Editorial Material，,卷期：2009年32-3] Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive [作者：Dormandy, J; Bhattacharya, M; de Bruyn, ARV,期刊：Drug safety, 页码：187-202 , 文章类型： Review，,卷期：2009年32-3] People with type 2 diabetes mellitus have an excess risk of macrovascular disease and a poorer prognosis. PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events) was a landmark study of secondary card... Reducing Harm Associated with Anticoagulation Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia [作者：Hursting, MJ; Soffer, J,期刊：Drug safety, 页码：203-218 , 文章类型： Review，,卷期：2009年32-3] Argatroban is a hepatically metabolized, direct thrombin inhibitor used for prophylaxis or treatment of thrombosis in heparin-induced thrombocytopenia (HIT) and for patients with or at risk of HIT undergoing percutaneous... Bisphosphonates and Atrial Fibrillation Systematic Review and Meta-Analysis [作者：Loke, YK; Jeevanantham, V; Singh, S,期刊：Drug safety, 页码：219-228 , 文章类型： Article，,卷期：2009年32-3] Background: Bisphosphonates are widely used in osteoporosis, but there have been concerns about a potential link between bisphosphonate therapy and atrial fibrillation. Objective: We aimed to systematically evaluate the ... Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK An Observational Study [作者：Fogg, C; Kasliwal, R; Shakir, SAW,期刊：Drug safety, 页码：229-237 , 文章类型： Article，,卷期：2009年32-3] Background: Pioglitazone is an antidiabetic drug that belongs to the thiazolidinedione (TZD) class of insulin-sensitizing agents. Adverse events to pioglitazone of potential severity are listed in the 'special warnings a... First-Trimester Itraconazole Exposure and Pregnancy Outcome A Prospective Cohort Study of Women Contacting Teratology Information Services in Italy [作者：De Santis, M; Di Gianantonio, E; Cesari, E; Ambrosini, G; Straface, G; Clementi, M,期刊：Drug safety, 页码：239-244 , 文章类型： Article，,卷期：2009年32-3] Background: Itraconazole is an effective fungal treatment; however, there are few human data on prenatal exposure. Objectives: To evaluate the major malformation rate in itraconazole pre-natally exposed infants. The seco... Drug Safety Information Through the Internet The Experience of an Italian Website [作者：Polimeni, G; Russo, A; Catania, MA; Aiello, A; Oteri, A; Trifiro, G; Calapai, G; Sautebin, L; Iacobelli, M; Caputi, AP,期刊：Drug safety, 页码：245-253 , 文章类型： Article，,卷期：2009年32-3] Background: The Internet may play a crucial role in the prompt provision of updated drug safety information. Nevertheless, limited knowledge of the English language among healthcare professionals or suboptimal search ski... Spontaneous ADR Reports as a Trigger for Pharmacogenetic Research A Prospective Observational Study in the Netherlands [作者：van Puijenbroek, E; Conemans, J; van Grootheest, K,期刊：Drug safety, 页码：255-264 , 文章类型： Article，,卷期：2009年32-3] Background: Information on genetic polymorphisms in drug-metabolizing enzymes is valuable when analysing the causal relationship between drug intake and an adverse drug reaction (ADR). Patients who have experienced an AD...